Get The Facts
Treating hepatitis C has come a long way, still some people also use alternative therapies in the hope of some added benefit.
For instance in a NIH-sponsored clinical trial for hepatitis C (HALT-C), a third of HCV and cirrhosis patients reported using herbal products - the most common was milk thistle.
If you are considering any dietary supplement for hepatitis C and have questions about potential side effects, or specific concerns about how they may interact with your current medications, this Thursday is a great opportunity to find out the facts from the experts.
June 13 at 3:00 p.m. ET, the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health will be hosting a chat on Facebook about the research and safety of herbal supplements.
The announcement:
NCCAM Facebook Chat on Dietary and Herbal Supplements
June 13, 2013 3:00 p.m. ET
We’ve recently launched our eBook version of our popular Herbs at a Glance series. Join us on our Facebook page for our first Facebook Chat about what the science says about these herbs. NCCAM experts Drs. Craig Hopp and John Williamson will be on hand to answer your questions.
Join us as we host or participate in live online chats that cover a variety of health topics. If we’re hosting, we’ll be focusing on complementary health approaches for a specific health topic. An expert in scientific and health issues will be available to answer your questions. Most chats will occur on the last Thursday of each month. Dates, times, and topics may change and will be announced on this page and through Twitter and Facebook.
To join a chat that we’re hosting, use the hashtag #nccamchat. If we’re participating in another organization’s chat, we’ll share the hashtag where the conversation is taking place.
Past Chats
CDC Chat on Hepatitis C —May 30, 2013
Chat Expert: Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention (CDC) and Dr. Hazel Dean, Deputy Director of CDC’s HIV, Hepatitis, STD and TB Prevention Center.
ABC Chat on Yoga and Meditation —May 21, 2013
Chat Expert: Dr. Richard Besser, ABC News’ Chief Health and Medical Editor
Archive of This Chat (Storify)
See all archived chats
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment